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Summary 
The  study of human  malaria  has  been hampered by the lack of small animal  models for the 
human-infecting malarial parasites. To approach this problem, the erythrocytic stages of the human 
malarial parasite Plasmodiumfakiparum  were adapted to in vitro growth in the presence of ascites 
fluid from mice homozygous for the severe-combined immunodeficiency (scid) mutation. Human 
red blood cells (hRBCs) infected with these adapted parasites were then injected i.p. into nonobese 
diabetic scid/scid (NOD/LtSz-sc/d) mice. With daily supplemental  intraperitoneal  boosts of uninfected 
hRBCs, parasites were detected in the peripheral circulation of these mice for an average of 7 d 
after injection.  Splenectomy of NOD/LtSz-scid mice increased both the level and duration  of 
parasitemia in the periphery, and it also promoted the circulation of mature sexual stage parasites 
(gametocytes). When Anopheline mosquitoes were allowed to feed on the splenectomized mice, 
the gametocytes were ingested by the mosquitoes and developed into oocysts in the mosquito 
midguts. To our knowledge, these results are the first demonstration of human malarial parasite 
propagation  in mice and transmission  of these parasites  to the invertebrate vector. 
H 
uman malaria remains a serious health threat in many 
tropical regions of the world despite decades of research 
aimed at combating this prevalent infection. The spread of 
drug-resistant parasites  has made prevention and control in- 
creasingly difficult, and no successful vaccine has been devel- 
oped yet, partly because parasite-human  host interactions, 
particularly the factors that mediate acquired resistance,  are 
poorly understood. Various life cycle stages found in the ver- 
tebrate host and in the invertebrate vector are targets for the 
many malaria  vaccines  that  are currently being  developed 
(reviewed in reference 1). Ultimately, vaccines must specifically 
target antigenically distinct human malarial parasites,  partic- 
ularly Plasmodium falciparum,  the most  deadly of the four 
human Plasmodial species, and must be tested in human sub- 
jects. Likewise, newly developed drugs must undergo exten- 
sive animal and human trials before being released for general 
antimalarial  use. 
While animal models of malaria have been indispensable 
in expanding our knowledge of the genus Plasmodium, there 
are limits to which observations in these systems can be ex- 
trapolated to human malaria.  The development of a murine 
model for falciparum malaria will greatly enhance our ability 
to study the pathophysiology of this infection and will facili- 
tate  the  pretesting  of candidate  drugs  and  vaccines,  thus 
reducing the need for costly and time-consuming human trials. 
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Materials and Methods 
Parasites.  Plasmodiumfaki~rum isolate NF54 and 3D7, a clone 
of  NF54, were maintained according to a modification of the method 
described by Trager and Jensen (2): standard culture medium con- 
tains 90% RPMI 1640 supplemented with 25 mM N-(2-hydroxy- 
ethyl)piperazine-N'-(2-ethanesulfonic  acid) (Ultrol grade; Calbio- 
chem-Novabiochem Corp., La Jolla, CA), 0.37 mM hypoxanthine 
(Sigma Chemical Co., St. Louis, MO), 28.6 mM sodium bicar- 
bonate, and 10% human serum or plasma. Over several passages, 
human  plasma was gradually  replaced with scid mouse  serum, 
plasma, or ascites fluid. In general, the replacement was done in 
1-1.5% increments, and parasites were acclimated to each increase 
of mouse fluid for a minimum  of three subcultures. The parasites 
used in these studies were maintained in medium containing  5% 
human  plasma and 5% ascites fluid (5+5 medium). 
Ascites.  C.B-17-scid/scid  (hereafter-scid) and BALB/c-scid mice 
were primed with an intraperitoneal  injection of pristane or IFA 
7 d before inoculation  with SP-2/0 myeloma cells. Ascites fluid 
was tapped three times 14-20 d after injection of cells and was col- 
lected in 5 mM EDTA. 
Mice.  Several  strains ofscid mice were used. C.B-17-scid, HKS/J 
(hr/hr)-scid, and w41//w41-scid  mice were derived from stocks at The 
Jackson Laboratory (Bar Harbor, ME). Male NOD/LtSz-scid mice 
were generated at The Jackson Laboratory by L. D. Shultz  and 
were used at 6-12 wk of age. They were housed in microisolator 
cages and were provided with sterilized food and water at all times. 
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mg/ml Trimethoprim (Gensia Laboratories, Ltd., Irvine, CA) was 
provided 3 d/wk. 
The strains of mice named above were screened for suitability 
for this study by a single injection of 2 ml i.p. of washed human 
red blood cells (hRBCs) at 60% hematocrit (hct). The appearance 
of these cells  in the peripheral circulation was monitored by exami- 
nation of venous blood (see below) at 24-h intervals. 
Parasite Injection.  Cultures  of parasites maintained in  5+ 5 
medium were grown to a parasitemia  of 3-5%. Fresh hRBCs were 
added to bring the parasitemia to 1%. Cells were washed twice 
in medium lacking ascites/plasma. 1.0 ml of hRBCs at 50% hct 
was injected i.p. into NOD/LtSz-scid  mice on day 0. Mice were 
boosted daily with i.p. injections of the same volume of fresh unin- 
fected hRBCs. 
Monitoring hRBC Level and Parasitemia in Peripheral Circulation. 
Heparinized blood was taken daily by lateral tail vein puncture; 
the hRBC level in circulation was determined by staining with 
an FITC-conjugated, blood group H antigen-specific lectin from 
Tetragonolobuspurpureas (Sigma Chemical Co.). The lectin was dis- 
solved at 1 mg/ml in PBS and used at 6.7-33/~g/ml.  1/~1 of cells 
was suspended  in 150 #I of the diluted lectin (in PBS) and incubated 
at room temperature in the dark for 30 min. After two washes 
with PBS, 1,000 cells were counted by UV-illuminated  fluorescence 
microscopy. At least 10,000 total ILBCs  per sample were counted 
on Giemsa-stained (Harleco Giemsa blood stain; EM Industries, 
Inc., Gibbstown, NJ) thin smears to determine total parasitemia. 
hRBC parasitemia was calculated using the following formula: 
hRBC parasitemia =  total parasitemia/fraction of total cells that 
are hRBCs. 
Mosquito Feedings.  Male  NOD/LtSz-scid mice  infected  with par- 
asitized hlLBCs 16-21 d previously  were anesthetized by an injec- 
tion of 1 mg i.p. of sodium pentobarbital  in saline. Anopheles stephensi 
and Anophelesfreebomi, starved for 3-4 h, were allowed to feed on 
the mice  through a nylon mesh for 20-30 rain. Blood-fed  mosquitoes 
were maintained  in an insectory (26  ~ C, 70-80% relative  humidity) 
and were dissected 7-10 d later. Midguts were examined  microscop- 
ically to score for oocysts. 
Reinvasion.  Mice were injected with  type  O +  parasitized 
hl~,BCs as described above and were boosted i.p. daily with unin- 
fected type A § hRBCs. A control animal was boosted with type 
O + hRBCs. All mice were killed on day 4, and cells were recov- 
ered from their peritoneal cavities. The vital dye hydroethidine  (Poly- 
sciences, Inc., Warrington, PA) was used to detect viable parasites 
(3). Briefly, hydroethidine was dissolved at 10 mg/ml in DMSO 
(Sigma Chemical Co.) and diluted 1:200 in PBS. 1/~1 of cells were 
mixed with 50 ~1 of this solution and incubated at 37~  in the 
dark for 20 min. After two washes with PBS, cells were stained 
(as described above) using an FITC-conjugated, blood group A an- 
tigen-specific  lectin from Helix aspersa (Sigma Chemical Co.). Par- 
asitized type A + hRBCs were identified by viewing under UV- 
illuminated fluorescence  microscopy using the appropriate filters. 
Results and Discussion 
A  primary requirement  for the  growth of blood stage 
malarial parasites is RBCs from a specific host species. Thus, 
in the development of a mouse model for P. fakiparum infec- 
tion, the mouse strain that is used must be able to maintain 
hkBCs for an extended period of time. Normal immuno- 
competent mice cannot serve as suitable hosts, since they have 
naturally occurring cross-reactive anti-hRBC antibodies that 
will cause immediate complement-mediated lysis of intro- 
duced hRBCs. On the other hand, scid mice completely lack 
antibodies and thus do not present this obstacle. 
To introduce hRBCs into the circulation gradually rather 
than instantaneously, we chose the i.p. over the i.v. route for 
hRBC administration. We have observed  that hRBCs in- 
jected i.p. into intact C.B-17-scid  mice appear rapidly in pe- 
ripheral circulation, presumably transported via lymphatic 
drainage (4, 5). However, once these cells enter the vascular 
space, they are cleared within 24 h (6). There are several pos- 
sible explanations for this phenomenon, hRBCs have been 
shown to be coated nonspecificaUy  with normal human serum 
immunoglobulins (7-9),  and macrophages, as part  of the 
reticuloendothelial system (RES), remove such opsonized par- 
ticles through Fc receptor-mediated endocytosis. In addition, 
it is possible that NK cells, which are intact in C.B-17-scid 
mice (10), might mediate their elimination. Finally, the mean 
corpuscular volume of normal adult hRBCs is 80-100/zm 3 
(11), whereas that of normal adult murine RBCs is 41-51 
~m  3 (12). Thus, in mice, hRBCs may be damaged during 
passage through undersized capillary beds and subsequently 
cleared by the RES. 
To investigate which of these factors account for hRBC 
clearance in immunodeficient mice, several genetic stocks of 
mice homozygous for the scid mutation were administered 
a single i.p.  dose of washed hRBCs. Since we had already 
determined that intact C.B-17-scid  mice are unable to sup- 
port hRBCs in the peripheral circulation, splenectomized C.B- 
17-scid mice were used to determine the role of the spleen. 
Hairless HRS/J (hr/kr)-scid mice, which have a presumptive 
macrophage defect (13), were included to determine the mag- 
nitude of hRBC clearance caused by the RES.  To address 
the issue  of volume difference between mouse RBCs and 
hRBCs, w41/w41 mice, which have a macrocytic anemia (14) 
and thus are naturally tolerant of larger cells in circulation, 
were examined for their ability to allow circulation of hRBCs. 
Finally, NOD/Lt mice, carriers of a combination of defects 
that might contribute to the persistence of hRBCs, were also 
tested. An FITC-conjugated lectin specific  for the human blood 
group H  antigen was used to differentiate between mouse 
and human P,  BCs obtained daily from venous circulation. 
hRBCs could not be detected in most of the mice tested past 
the 3rd d after injection. NOD/LtSz-scid mice, however, sup- 
ported a high level of circulating hRBCs and maintained these 
cells for 5-6 d (Fig.  1).  The latter strain manifests at least 
four defects that might contribute to this phenomenon. The 
first is the result of a mutation in the gene that encodes the 
high af~nity Fc receptor for immunoglobulin G, FcyRI, which 
might reduce Fc receptor-mediated endocytosis in macro- 
phages (15). These mice also exhibit abnormally low NK cell 
activity (16) and have a mild macrocytic anemia (17). Finally, 
as a result of a mutation in the gene that encodes the fifth 
component of complement (C5), these mice are deficient in 
hemolytic activity (17, 18). Based on these data, we concluded 
that NOD/LtSz-scid mice may be appropriate for maintaining 
P. falcipamm-infected  hRBCs. 
In our initial attempts to condition P. fakiparum for injec- 
tion into mice, we partially replaced  the human plasma in 
2266  Maintenance  of P. fakiparum in scid Mice and Transmission to Mosquitoes 30 
Z 
0 
I'-  < 
.J 
(J 
rr 
Z 
0 
25- 
20- 
15- 
10- 
5- 
0 
0 
,~  ,,p 
5  6 
DAYS  POST-INJECTION 
Figure  1.  Appearance  of  hRBCs  in  the  peripheral  circulation  of 
NOD/LtSz-scid mice after a single i.p. injection. 
in vitro culture medium with scid mouse serum or plasma. 
We found that  parasites  were rendered nonviable at a con- 
centration  of mouse  serum  or  plasma  i>5%  of the  total 
medium volume. This observation indicated to us that  the 
murine environment is potentially inhospitable for parasites, 
and it supported our notion that adaptation of parasites  be- 
fore introduction  into  the mice would be necessary.  Since 
we intended to inject the parasites  i.p.,  we also tested the 
ability of ascites fluid from scid mice to support growth in 
vitro. In contrast to mouse serum or plasma, murine ascites 
was well tolerated up to 7 or 8% of the total culture volume. 
Thus, ascites-adapted parasites  were used in all of the experi- 
ments described below. 
Infection of intact  male NOD/LtSz-scid mice was initi- 
ated with  a  single i.p.  injection  of 1.0  ml  hRBCs  at  1% 
parasitemia.  The mice were boosted daily with i.p. injections 
of the same volume of fresh, uninfected hRBCs because as 
much as 90% of the injected volume is transported  out of 
the peritoneal cavity into the vascular space within 24 h. Cells 
infected with all asexual parasite forms (rings, trophozoites, 
and,  to a lesser extent,  schizonts) were detected in the pe- 
ripheral circulation  up to 10 d after injection (Fig. 2 B, squares). 
Although splenectomy did not result in increased persis- 
tence of hRBCs in the circulation of C.B-17-scid mice, it did 
have a profound effect in NOD/LtSz-scid mice that had been 
injected with parasite-infected cells. While not significantly 
altering the ratio of human/mouse RBCs in circulation (Fig. 
2 A),  splenectomy resulted in markedly increased levels of 
parasitized hRBCs in circulation and a longer  time period 
during which these cells could be detected (Fig.  2 B, circles). 
There was considerable variability in levels of parasitemia be- 
tween individual mice in each group, and in a few cases, in- 
tact mice revealed  values within the range observed for the 
splenectomized group. Nevertheless, the data in Fig. 2 repre- 
sent  a clear  trend  toward improved  support  of parasitized 
hRBCs in splenectomized versus intact NOD/LtSz-scid mice. 
Parasites  isolated from the peripheral  circulation  of both 
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Figure  2.  Comparison of hRBCs in circulation and parasitemia between 
intact and splenectomized NOD/LtSz-scid mice after i.p. injection of par- 
asitized hRBCs. (A) Geometric means of circulating hRBC levels in in- 
tact (squares) and splenectomized (circles) mice. (B) Geometric means of 
hRBC parasitemias in both groups. Note the difference in lengths of time 
that intact and splenectomized mice supported parasites in circulation. For 
intact mice, n  =  7 (days 1-5); n  =  5 (days 6 and 7);  n  =  1 (days 8-10). 
Intact mice were removed from study when parasitemia fell below 0.1%. 
For splenectomized mice, n  =  6 (days  1-6);  n  =  5 (days 7-10);  n  =  4 
(days 11 and 13); n  =  1 (days 12, 14, and 15). Splenectomized mice were 
removed from study when parasitemia fell below 0.2%  (n  =  3) or for 
use in gametocyte transmission  experiments  (n  =  3,  day 14) (see Table 
1).  For clarity, we have not shown the data  for each individual mouse. 
Data are derived from three independent  experiments. 
intact and splenectomized NOD/LtSz-scid mice were iden- 
tical to those found in in vitro cultures (Fig.  3, A-C).  Oc- 
casional  parasites  appeared  unhealthy  (Fig.  3  D),  perhaps 
damaged during injection or by inflammatory factors in the 
peritoneal cavity. For the most part, however, parasites that 
were recovered from both the peritoneal cavity and periph- 
eral circulation of infected mice were viable, displaying  normal 
growth kinetics when reintroduced  into culture. 
2267  Moore et al.  Brief Definitive Report Figure 3.  Light micrographs  of various parasite stages isolated from 
the peripheral circulation of P. falciparum-infected NOD/LtSz-scid mice. 
(,'t) Early trophozoites, (B) a schizont, (C) mature gametocytes  and a murine 
neutrophil, and (D) an unhealthy schizont with few segmenters. Bar, 5/zm. 
Figure 4.  Representative micrographs of parasitized hRBCs recovered 
from the peritoneal cavities of NOD/LtSz-scid mice that were injected 
with P. fakitmmm-infected type O hRBCs.  (A-C) hRBCs derived from 
a mouse boosted with type A hRBCs. (D-F) hRBCs derived from a con- 
trol animal that received only type O hRBCs.  (A and D) Hydroethidine 
staining of parasite RNA and DNA. (B and E) Blood group A-specific, 
FITC-conjugated  lectin staining. Note that because of the wide emission 
spectrum  of ethidium, the parasites can also be seen using the filters for 
FITC emission (A vs B) and (D vs E). (C and F) Light microscopy of 
same fields shown in A and B and D and E, respectively Note that type 
A (FITC-labeled)  but not type O (unlabeled)  cells  are agglutinated by lectin. 
The bemozoin crystal in both cases is visible (100x). 
To formally prove that reinvasion  of  fresh uninfected hRBCs 
occurs in the mice, infection was initiated with human blood 
group O  (type O) erythrocytes,  and it was followed with 
i.p. boosts of human blood group A (type A) cells. A blood 
group antigen A-specific lectin was used to distinguish  type 
O  hRBCs from type A hRBCs, and parasites were stained 
with the vital dye hydroethidine. Examination of cells recov- 
ered from the peritoneal cavities of NOD/LtSz-scid mice 4 d 
after initiation of infection with parasitized type O hRBCs 
revealed parasites in type A cells (Fig. 4 A-C). 
In addition to acting as suitable reservoirs for asexual stage 
parasites, splenectomized mice supported the maturation and 
circulation of gametocytes. The relative proportions of sexual 
to asexual forms (Fig. 5) and the total numbers of gameto- 
cytes (see below) increased over time, and by ~16 d after in- 
jection, gametocytes were the predominant parasite forms in 
circulation.  Fully mature male and female gametocytes were 
generally detected beginning ~13 d after injection and were 
morphologically indistinguishable from those seen in in vitro 
cultures  (Fig.  3 C). 
Because the inoculating parasites contained low levels of 
gametocytes (0-3%), it could be argued that the increase in 
gametocytemia  over time (Fig. 5) represents preferential sur- 
vival of sexual versus asexual parasites. However, additional 
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Figure 5.  Fraction of sexual parasite forms as a percentage of all para- 
sites found in circulation of splenectomized NOD/LtSz-scid mice after in- 
jection of infected hRBCs. Experiments performed with P. falciparum  clone 
3D7.  n  =  12 (days 1-5);n  =  11 (day 6);n  =  10 (days 7 and 8); n  = 
8 (days 9 and 10); n  =  7 (day 11); n  =  3 (day 12); n  =  6 (day 13); and 
n  =  4 (days 16 and 18). Data represent means  _+ SD of four separate ex- 
periments. Paired t test analysis  shows that the value for day 16 is significantly 
higher  than those for days 1-4 and 7 (P <0.025)  and day 9 (P <0.03). 
Likewise, the value for day 12 is significantly higher  than those for day 
1 (P <0.04)  and days 3,  7, and 8 (P <0.02). 
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Mouse  Days P.I.S  Oocysts/midgutn  Positive/total 
849*  16 
850*  16 
851"  16 
859*  17 
860*  17 
892*  16 
893*  16 
892~  17 
893*  17 
892~  21 
893*  21 
1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0 
1,3,0,0,0,2,0,0,0,0,0,0,1,1 
1,0,1,0,0,0,0,0,0,0,2,0,0,0,0,0 
0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0 
0,0,0,0,0,1,0,0,0,0,0 
2,0,0,0,0,1,0,0,0,0,2,0,1,0,0,0,3,0 
1,0,0,0,1,1,1,1,1,0,0,0,1,2,0 
3,0,2,0,1,1,1,0,0,0,0,1,4,2,0,1,1,0,4,0 
0,0,1,0,0,1,0,0,0,0,0 
4,0,0,0,0,1,3,0,2,1,2,0,0,4,0,2,0,0,0,0,0,1,1,0,0,1,1,3 
1,0,0,0,0,2,1,1,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,0,0,1,0,0,0 
4:19 
5:14 
3:16 
Total  =  12:49 
2:16 
1:11 
Total  =  3:27 
5:18 
8:15 
11:20 
2:11 
13:28 
7:29 
Total  =  46:121 
Infectiousness of circulating gametocytes from splenectomized NOD/LtSz-scid  mice to A. stephensi and A. freeborni. Mosquitoes,  starved for 3-4 h, 
were  allowed to feed through a nylon mesh on anesthetized  mice that had been infected with parasitized hRBCs (*clone 3D7 or isolate #NF54) 
16-21 d previously. Blood fed mosquitoes were dissected 7-10 d later,  and their midguts were examined microscopically to score for oocysts. Data 
represent  three independent experiments. 
S Days post-injection. 
II A. freeborni was used with mice 859 and 860; A. stephensi was used with all others. 
observations suggest that this increase resulted from in situ 
generation, and not from preferential persistence, of sexual 
forms. First, the appearance of gametocytes varied from day 
to day, i.e., a mouse with many garnetocytes (at various matura- 
tional stages) on one day did not necessarily display the same 
amount or the same stages on the next day. Second, by our 
calculations, the absolute number of gametocytes in mouse 
circulation late in infection was as much as 20-fold greater 
than the input (inoculum) number. 
Finally, in humans, the gametocyte generation time is 10- 
12 d (19), after which mature parasites have a half-life of 2.5 d 
in circulation (20);  thus,  sexual parasites  present in the in- 
ocula would have matured and begun to disappear no later 
than on days 14-15,  before the date on which we observed 
peak gametocytemia (Fig. 5, day 16) and performed mosquito 
blood feeds  (see below,  and Table  1,  d  16-21). 
To determine whether the gametocytes found in NOD/ 
LtSz-scid mice were infectious, A. stephensi and A. freeborni 
mosquitoes were allowed to feed on mice that had been in- 
fected at least 16 d previously. In three independent experi- 
ments, oocysts were detected in the mosquito midguts 7-10 d 
after feeding, demonstrating transmission (and infectiousness) 
of P. falciparum from NOD/LtSz-scid mice to Anopheline 
mosquitoes (Table  1).  A  strain (NF54) known to produce 
high numbers of gametocytes in vitro was used in one ex- 
periment. Importantly, in our culture conditions, these para- 
sites did not generate levels of gametocytes that were statisti- 
cally significantly different from  those  of clone 3D7.  In 
addition, the generation of gametocytemia in NF54-infected 
NOD/LtSz-scid  mice was similar to that  seen  with 3D7- 
infected mice (Fig.  5).  Nonetheless, mosquito blood feeds 
on the former mice resulted in markedly improved transmis- 
sion (Table 1). It is noteworthy that these transmission rates 
are comparable with those reported in human infections (21). 
In conclusion, we have successfully maintained both the 
sexual and asexual stages of P. fakiparum  in NOD/LtSz-scid 
mice for extended periods of time and have shown that the 
sexual parasites are transmittable to mosquitoes. The useful- 
ness of this model in the study of human malaria should be 
far reaching. With improved levels of asexual parasites, it should 
be possible to test antimalarial drugs. Perhaps most signi- 
ficantly, NOD/LtSz-scid mice are exceptionally suited to recon- 
stitution with human immune cells (22).  It should then be 
possible to reconstitute these mice, immunize them with can- 
didate antigens, and infect them to study the human immune 
response to P. falciparum. 
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